DNAPKcs-ETS1 Axis Unlocks New TNBC Treatment Strategy
A newly discovered molecular mechanism explains how triple-negative breast cancer develops resistance to chemotherapy. The DNAPKcs-ETS1 axis represents a promising therapeutic target for overcoming treatment resistance.
